The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: A clinical study of 19 cases

Division of Hematology, Department of Internal Medicine, Uludag University School of Medicine, Uludag University Hospital, Bursa, Turkey.
BMC Cancer (Impact Factor: 3.32). 02/2005; 5:144. DOI: 10.1186/1471-2407-5-144
Source: PubMed

ABSTRACT Although bone marrow metastases can be found commonly in some malignant tumors, diagnosing a nonhematologic malignancy from marrow is not a usual event.
To underscore the value of bone marrow aspiration and biopsy as a short cut in establishing a diagnosis for disseminated tumors, we reviewed 19 patients with nonhematologic malignancies who initially had diagnosis from bone marrow.
The main indications for bone marrow examination were microangiopathic hemolytic anemia (MAHA), leukoerythroblastosis (LEB) and unexplained cytopenias. Bone marrow aspiration was not diagnostic due to dry tap or inadequate material in 6 cases. Biopsy results were parallel to the cytological ones in all cases except one; however a meticulous second examination of the biopsy confirmed the cytologic diagnosis in this patient too. The most common histologic subtype was adenocarcinoma, and after all the clinical and laboratory evaluations, the primary focus was disclosed definitively in ten patients (5 stomach, 3 prostate, 1 lung, 1 muscle) and probably in four patients (3 gastrointestinal tract, 1 lung). All work up failed in five patients and these cases were classified as tumor of unknown origin (TUO).
Our series showed that anemia, thrombocytopenia, elevated red cell distribution width (RDW) and hypoproteinemia formed a uniform tetrad in patients with disseminated tumors that were diagnosed via bone marrow examination. The prognosis of patients was very poor and survivals were only a few days or weeks (except for 4 patients whose survivals were longer). We concluded that MAHA, LEB and unexplained cytopenias are strong indicators of the necessity of bone marrow examination. Because of the very short survival of many patients, all investigational procedures should be judged in view of their rationality, and should be focused on treatable primary tumors.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Background: Novel biomarkers are needed to predict the response to treatment in patients with nephrotic syndrome (NS) due to primary glomerulonephritides (PGN). We aimed to test the predictive value of red blood cell distribution width (RDW) for estimation of response to therapy in adult patients with NS. Study design, setting & participants, and intervention: We performed a prospective study including 176 patients with NS due to PGN. Patients were divided into three groups according to their response to the treatment. Group 1 was composed of patients with complete remission whereas group 2 was composed of patients with partial remission and group 3 was composed of patients who were resistant to the treatment. Results: The highest baseline mean RDW value was found in group 3 patients (17.8 ± 1.8) whereas the lowest in group 1 (13.4 ± 0.7) before treatment (p < 0.05). We found a significant decrease in RDW value after an effective treatment in groups 1 and group 2 (p < 0.05). However, there was no significant change in RDW values after treatment in group 3 (p > 0.05). Most of the patient with complete remission had base-line RDW level ≤ 14% (n = 45, 90%) (p < 0.001, Kendal Tau: -0.86), and most of the patients who were resistant to the treatment had base-line RDW level p > 15% (n = 68, 86.1%) (p < 0.001, Kendal Tau: -0.87). Conclusion: Our results suggest that pre-treatment RDW value is a promising novel biomarker for predicting response to the treatment in adult patients with NS due to PGN.
    Renal Failure 06/2014; DOI:10.3109/0886022X.2014.926771 · 0.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer is the first in the incidence of malignancies among women. The documented frequency of osseous metastasis from breast cancer is about 12.8 %. Although breast cancer cells have been documented in the bone marrow in autopsy, haematological manifestations due to metastatic disease to the marrow is rare. The prognosis of these cases is dismal and improper management worsen the condition further. IHC for ER, PR & Her 2/neu status plays a vital role in ascertaining the treatment protocol both in primary tumors as well as metastatic or recurrent tumors. Receptor conversion has been documented in metastatic and recurrent cases. We report a case of 65 year female with a history of ER, PR positive and Her 2/neu negative carcinoma breast 3½ years back, presented with anemia and low back ache diagnosed as metastatic breast carcinoma to bone marrow with receptor conversion.
    Indian Journal of Hematology and Blood Transfusion 09/2014; 30(Suppl 1):338-40. DOI:10.1007/s12288-014-0394-0 · 0.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Necrotizing fasciitis (NF) is a rapidly progressing and potentially lethal infectious disease of the soft tissue. An elevated red blood cell distribution width (RDW) is associated with increased risk of death in patients with heart disease and infectious disease. We retrospectively assessed the association of elevated RDW with in-hospital mortality due to NF. Methods All patients had diagnoses of NF and were admitted to the emergency department of a single institution in Taiwan over a 4 year period. Demographics, co-morbidities, clinical presentations, and laboratory parameters were retrospectively reviewed. RDW was categorized as elevated (> 14.5%) or not elevated. Multivariate regression analysis was used to identify risk factors associated with mortality. Results A total of 98 patients were enrolled, and the mortality rate was 23%. Univariate analysis indicated that advanced age, initial hypotension, low hemoglobin level, and elevated RDW (69.6% vs. 20%, OR = 9.14, p < 0.001) were significantly associated with mortality. Multivariate analysis indicated that RDW was a significant and independent predictor of mortality in enrolled patients. Conclusions Elevated RDW is a significant and independent predictor of in-hospital mortality for patients with NF.
    American Journal of Emergency Medicine 10/2014; 32(10). DOI:10.1016/j.ajem.2014.08.001 · 1.15 Impact Factor

Preview (2 Sources)

1 Download
Available from